ADMA Biologics (ADMA) Prelim. Q4 Revenue Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| ADMA Biologics Inc Com (NASDAQ: ADMA) | Delayed: 11.05 -0.01 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.06 | 52 Week High | $9.65 | |||
| Open | $11.02 | 52 Week Low | $4.15 | |||
| Day High | $11.08 | P/E | N/A | |||
| Day Low | $10.90 | EPS | $-0.01 | |||
| Volume | 284,372 | |||||
